SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Collagen Corp.
CGEN 1.750-1.1%Nov 3 3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: starpopper who wrote (2)3/5/1997 10:49:00 AM
From: Rocketman   of 72
 
IMHO CGEN seems to have possibilities due to their holding 1.3 M shares of Target Therapeutics worth about $95-100 M. By my guestimates they are trading at or below book value. How many other profitable biotechs trade at book with a PE of 6-7 and pay a 1% yield to boot? So why the depressed stock price? I figure it's because nobody likes their management (I never have) which is marginal at best. Plus, they have a history of overhyping the company. If I was looking for a good acquisition target, CGEN is the type that has the assets that could be plundered to finance a deal, and nobody would miss the execs after the fact. Also, with the new breast implant, and other products in the pipeline they have some improved revenue potential. The other interesting thing about CGEN is that they have been effective at incubating other biotechs that they either spin off ie.) Target T. or that they reassimilate ie.) LipoMatrix (breast implant). I'd just never want to work for these guys - no fun.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext